Abstract

Introduction: Upper airway stimulation via the hypoglossal nerve stimulator (HGNS) implant is a surgical method for treating obstructive sleep apnea. However, patients may need the implant removed for a variety of reasons. The purpose of this case series is to assess surgical experiences with HGNS explantation at our institution. We report on surgical approach, overall operative times, operative and postoperative complications, and discuss relevant patient-specific surgical findings when removing the HGNS. Methods: We performed a retrospective case series of all patients that underwent HGNS implantation at a single tertiary medical center between January 9, 2021, and January 9, 2022. Subjects included adult patients who presented to the sleep surgery clinic of the senior author for surgical management of previously implanted HGNS. Patient clinical history was reviewed to determine the timing of the patient’s implant, reasons for explant, and postoperative recovery course. Operative reports were reviewed to determine overall duration of surgery and any associated difficulties or deviations from the general approach. Results: Between January 9, 2021, and January 9, 2022, 5 patients had an explantation of their HGNS implant. Explantation occurred between 8 and 63 months of their original implant surgery. The average operative time from incisional start time to close was 162 min for all cases with a range of 96–345 min. No significant complications were reported including pneumothorax and nerve palsy. Conclusion: This reported case series outlines the general steps for Inspire HGNS explantation as well as details the experiences in a case series of 5 subjects explanted over the year at a single institution. The results from the cases suggest that the explantation of the device can be performed efficiently and safely.

© 2023 S. Karger AG, Basel

References Strollo PJ Jr, Soose RJ, Maurer JT, de Vries N, Cornelius J, Froymovich O, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. 2014 Jan;370(2):139–49. Rathi VK, Kondamuri NS, Naunheim MR, Gadkaree SK, Metson RB, Scangas GA. Use and cost of a hypoglossal nerve stimulator device for obstructive sleep apnea between 2015 and 2018. JAMA Otolaryngol Head Neck Surg. 2019 Oct;145(10):975–7. Thaler E, Schwab R, Maurer J, Soose R, Larsen C, Stevens S, et al. Results of the ADHERE upper airway stimulation registry and predictors of therapy efficacy. Laryngoscope. 2020 May;130(5):1333–8. Woodson BT, Soose RJ, Gillespie MB, Strohl KP, Maurer JT, de Vries N, et al. Three-year outcomes of cranial nerve stimulation for obstructive sleep apnea: the STAR trial. Otolaryngol Head Neck Surg. 2016 Jan;154(1):181–8. “Inspire MRI Guidelines for Inspire Therapy.” Jul. 08, 2022. [Online]. Available from: https://manuals.inspiresleep.com/. Yu JL, Thaler ER. Hypoglossal nerve (cranial nerve XII) stimulation. Otolaryngol Clin North America. 2020 Feb;53(1):157–69. Heiser C, Steffen A, Boon M, Hofauer B, Doghramji K, Maurer JT, et al. Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry. Eur Respir J. 2019;53(1):1801405. Kent DT, Chio EG, Weiner JS, Heiser C, Suurna MV, Weidenbecher M. A noninferiority analysis of 3- vs 2-incision techniques for hypoglossal nerve stimulator implantation. Otolaryngol Head Neck Surg. 2022 Jun;167(1):197–202. Author Contacts

Jason Lee Yu, jason.lee.yu@emory.edu

Article / Publication Details

First-Page Preview

Received: November 04, 2022
Accepted: December 17, 2022
Published online: February 16, 2023

Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 1

ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)

For additional information: https://www.karger.com/ORL

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.